Association of Anti-VEGF Injections with Progression of Geographic Atrophy

Area of Science:

• Ophthalmology
• Retinal Diseases
• Medical Treatments

Background:

• Age-related macular degeneration (AMD) is a primary cause of vision loss in individuals over 60.
• Wet AMD involves abnormal blood vessel growth and leakage, treated with anti-VEGF injections.
• Geographic atrophy (GA) is characterized by significant retinal pigment epithelium loss.

Purpose of the Study:

• To review and discuss the evidence regarding the potential association between anti-VEGF injections and the progression of geographic atrophy (GA) in patients with age-related macular degeneration (AMD).

Main Methods:

• Literature review of studies investigating the effects of anti-VEGF treatments on AMD progression.
• Analysis of clinical data and research findings concerning the relationship between intravitreal anti-VEGF therapy and geographic atrophy development.

Main Results:

• Evidence suggests a potential link between the use of anti-VEGF injections for wet AMD and an increased rate of geographic atrophy (GA) progression.
• The review synthesizes findings that raise concerns about this association in the context of AMD management.

Conclusions:

• Further research is warranted to fully understand the impact of anti-VEGF therapy on GA progression.
• The findings highlight a critical consideration for ophthalmologists managing patients with both wet AMD and GA.